Topics Regions
BioCell2

New guidance will help Indian supplement firms meet new regulatory requirements

Two new guides have been published in India to help the country’s health supplement industry adapt to recently implemented regulatory requirements. 

The documents have been produced by ReCHaN – the Resource Centre for Health Supplements and Nutraceuticals – which was established in July 2017 through a partnership between the Confederation of Indian Industry (CII) and the International Alliance of Dietary/Food Supplement Associations (IADSA). They can be downloaded at www.rechan.in.

The two organisations say their publication is significant because they are seen as a stepping stone towards ensuring consistency of practice across India’s supplement industry, and assisting in the application of legislation governing the sector.

• The Health Supplements and Nutritionals Compliance Guidance Document addresses new regulations introduced at the beginning of 2018 to regulate the industry. It covers product definitions, labelling requirements, ingredients and rules on licensing and importation. It also considers the international regulatory perspective and situations where an issue of interpretation may arise. The document will help move India’s supplement businesses towards global alignment and will be updated as and when new information arises.

• The Health Supplements and Nutraceuticals Guidance Document on Good Manufacturing Practices explains procedures for ensuring high standards of safety, hygiene, quality and traceability, among others. Produced in partnership with the Food Safety Standards Authority of India (FSSAI), it provides foundation level requirements for the manufacture of health supplements within India’s food safety system. These requirements are based on the core elements of Indian standards, as well as international best practices, and have been developed to be achievable by all companies, large and small.

Their publication follows the signing earlier this year of a Memorandum of Understanding (MoU) between FSSAI, CII and IADSA. The three bodies have agreed to work together in order to give ReCHaN the support it needs to strengthen India’s health supplements sector.

Mr. Simon Pettman Executive Director of IADSA, said:

“The health supplement and nutraceutical sector is set to grow significantly in India. IADSA is delighted to cooperate so closely with FSSAI and CII to share our global expertise to help build a sound framework for the development of regulation, science and policy.”

Based in New Delhi, FSSAI sets science-based standards across India for the manufacture, storage, distribution, sale and import of food products. It is responsible for developing, implementing and enforcing India’s regulation on the safety of health supplements and nutraceuticals. Visit fssai.gov.in for more information.

Also located in New Delhi, CII is a non-government, not-for-profit, industry-led organization that supports the development of India’s economy. It is India’s premier business association with more than 8,500 members from the private and public sectors. Visit cii.in for more information.

Based in London, IADSA is the international association of the food supplement sector, with members from six continents. It provides the global platform to guide the evolution of policy and regulation in the sector. Visit iadsa.org for more information.

Main image: FSSAi-ReCHaN second stakeholder meeting. ReCHaN

, , , ,

About the Author

Jim Manson

Writer & Editor
Jim Manson is editor-in-chief of Diversified Communications UK‘s natural and organic publishing portfolio. He’s written widely on environment and development issues for specialist magazines and national media, including the Financial Times, The Guardian, The Times, and World Bank Urban Age

Articles by Jim Manson

Online Profiles:NPGalerts  

Jim Manson
No comments yet.

Comments

NGE
BioCell2

Subscribe for your FREE weekly newsletter

Get the latest natural & organic news delivered straight to your inbox every week

NPG Sponsored

More from NPG Sponsored
NGE
BioCell2